Yoga & naturopathy-based telemedicine as an adjuvant therapy in improving quality of life and alleviating anxiety and depression in mild to moderate COVID-19 patients who are in home quarantine. A non-randomized control trial
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Reduction in Anxiety and depression assessed by DASS 21 scale, improvement in QOL assessed by WHO-Bref, Improvement in symptoms
研究概览
简要总结
COVID-19 has induced a lot of distress across the nation. Medical fraternities of different disciplines are putting their best foot forward to combat this deadly virus. Yoga & Naturopathy is an evidence based system of medicine that can complement the conventional care in bringing better results. The outcome of this research will facilitate in helping many more patients across the globe that these interventions are beneficial. the patients will recieve either yoga and naturopathy based lifestyle modification or meditation in addition to the standard of care. We will be evaluating the changes in QOL and anxiety and depression along with symptom score in mild to moderate covid 19 positive patients who are in home quarantine.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 18.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •All positive mild and moderate COVID-19 cases who are receiving standard care and are in home quarantine.
- •Patients willing to consent to participate in the study.
排除标准
- •All positive mild and moderate COVID-19 cases who are in hospital care Patients who require supplemental oxygen therapy Pregnant and lactating mothers Patients who are under 18 years of age.
结局指标
主要结局
Reduction in Anxiety and depression assessed by DASS 21 scale, improvement in QOL assessed by WHO-Bref, Improvement in symptoms
时间窗: At baseline Baseline | Anxiety and depression assessed by DASS 21 scale, Quality of Life assessed by WHO-BREF | At 14th Day from baseline | Anxiety and depression assessed by DASS 21 scale, Quality of Life assessed by WHO-BREF
次要结局
- Improvement in symptoms(Baseline and daily till 14 days)